# Safety of Photodynamic Therapy (PDT) in the Ablation of High-grade Dysplasia (HGD) in Barrett's Esophagus (BE)

> **NCT01209013** · PHASE3 · WITHDRAWN · sponsor: **Pinnacle Biologics Inc.**

## Conditions studied

- Barrett Esophagus

## Interventions

- **DEVICE:** Medlight PDT Balloon
- **PROCEDURE:** Endoscopy
- **PROCEDURE:** Endoscopy with biopsy
- **PROCEDURE:** Electrocardiogram
- **PROCEDURE:** Chest x-ray
- **PROCEDURE:** Blood collection
- **PROCEDURE:** Tissue sample collection

## Key facts

- **NCT ID:** NCT01209013
- **Lead sponsor:** Pinnacle Biologics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor cancelled the study
- **Last updated:** 2012-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01209013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01209013, "Safety of Photodynamic Therapy (PDT) in the Ablation of High-grade Dysplasia (HGD) in Barrett's Esophagus (BE)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01209013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*